Barclays Maintains Equal-Weight on Astrana Health, Raises Price Target to $37

Benzinga Newsdesk www.benzinga.com Positive 72.9%

Neg 0% Neu 0% Pos 72.9%

Barclays analyst Andrew Mok maintains Astrana Health (NASDAQ:ASTH) with a Equal-Weight and raises the price target from $26 to $37.